Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 910,411 | 936,464 | 1,022,960 | 989,501 | 905,526 |
| Marketable Securities | 392,344 | 182,926 | N/A | N/A | N/A |
| Receivables | 404,956 | 355,284 | 323,907 | 295,598 | 311,369 |
| Inventories | 105,196 | 112,627 | 101,856 | 94,521 | 90,049 |
| Income taxes - deferred | 23,820 | 19,892 | 19,995 | 26,086 | 19,177 |
| TOTAL | $1,915,502 | $1,678,633 | $1,550,041 | $1,495,600 | $1,410,391 |
| Non-Current Assets | |||||
| PPE Net | 178,842 | 173,721 | 164,966 | 165,629 | 165,047 |
| Intangibles | 900,211 | 897,325 | 899,038 | 900,323 | 902,145 |
| Other Non-Current Assets | 55,240 | 65,559 | 71,836 | 52,008 | 28,025 |
| TOTAL | $1,134,293 | $1,136,605 | $1,135,840 | $1,117,960 | $1,095,217 |
| Total Assets | $3,049,795 | $2,815,238 | $2,685,881 | $2,613,560 | $2,505,608 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 |
| Accounts payable and accrued liabilities | 24,416 | 25,587 | 25,586 | 21,488 | 21,962 |
| Accrued Expenses | 255,784 | 188,759 | 186,959 | 249,787 | 247,885 |
| Other current liabilities | 12,885 | 7,757 | 5,415 | 9,548 | 9,025 |
| TOTAL | $395,456 | $302,978 | $295,747 | $360,089 | $361,942 |
| Non-Current Liabilities | |||||
| Long Term Debt | 77,000 | 89,000 | 101,000 | 101,000 | 113,000 |
| Deferred Revenues | 54,371 | 32,875 | 29,787 | 31,266 | 35,070 |
| Other Non-Current Liabilities | 196,715 | 184,111 | 177,961 | 161,794 | 158,231 |
| TOTAL | $299,573 | $300,720 | $300,081 | $282,621 | $271,231 |
| Total Liabilities | $695,029 | $603,698 | $595,828 | $642,710 | $633,173 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 196,074 | 195,558 | 195,147 | 195,209 | 194,286 |
| Common Shares | 20 | 20 | 20 | 20 | 19 |
| Retained earnings | 398,090 | 304,305 | 208,420 | 126,203 | 45,230 |
| Other shareholders' equity | -12,588 | 19,161 | 30,626 | 6,406 | 2,669 |
| TOTAL | $2,354,766 | $2,211,540 | $2,090,053 | $1,970,850 | $1,872,435 |
| Total Liabilities And Equity | $3,049,795 | $2,815,238 | $2,685,881 | $2,613,560 | $2,505,608 |